US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

ATXS Astria Therapeutics Inc

9.50

0.32 (3.49%)

01 May 2024 - Cerrado

Retrasado por 15 minutos

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Astria Therapeutics (NASDAQ:ATXS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Astria Therapeutics.

Astria Therapeutics (NASDAQ:ATXS)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Astria Therapeutics.

Noticias sobre Astria Therapeutics Inc ATXS

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
Martes 9 de Abril 2024 (3 semanas hace) • Business Wire

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Miércoles 3 de Abril 2024 (4 semanas hace) • Business Wire

Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
Lunes 25 de Marzo 2024 (1 mes hace) • Business Wire

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Martes 5 de Marzo 2024 (2 meses hace) • Business Wire

Form 8-K - Current report
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Lunes 4 de Marzo 2024 (2 meses hace) • Business Wire

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
Martes 20 de Febrero 2024 (2 meses hace) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 14 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 14 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 14 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Astria Therapeutics Inc Artículos de Noticias

Invesco QQQ Trust Series 1

Health Care Select Sector

Energy Select Sector SPDR

Deutsche Telekom (QX)

US Dollar vs MXN

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones